Is Topiramate a GLP-1? Weight Loss Drug Differences

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Topiramate is an anticonvulsant medication that has shown modest weight loss benefits in clinical research, but it is fundamentally different from GLP-1 receptor agonists like semaglutide and tirzepatide. Many people confuse these drug classes because both can support weight management, yet they activate entirely separate biological pathways in the brain and body.

What Is Topiramate and How Does It Work for Weight Loss?

Topiramate was originally developed to treat epilepsy and prevent migraines, with weight loss discovered as a side effect during clinical trials. The medication works by enhancing the activity of GABA, a neurotransmitter that calms brain signals, and blocking carbonic anhydrase enzymes that affect neural function. This dual action may reduce appetite and increase feelings of fullness, though the weight loss effects are typically modest compared to newer medications.

Clinical studies have shown topiramate can produce weight reductions of 5 to 10 percent of body weight over several months, making it significantly less potent than GLP-1 receptor agonists. The medication is often prescribed off-label for weight management, though it was not designed specifically for this purpose. Common side effects include tingling sensations, cognitive changes, and potential birth defects, which limits its use in certain patient populations.

GLP-1 Receptor Agonists: A Different Class of Weight Loss Medication

Semaglutide and tirzepatide belong to the glucagon-like peptide-1 receptor agonist family, medications that mimic natural hormones controlling blood sugar and appetite. GLP-1 drugs bind directly to specific receptors in the brain and pancreas, triggering signals that slow stomach emptying, reduce hunger, and increase satiety—making patients feel satisfied with smaller meals. These medications were originally developed for type 2 diabetes and later approved for chronic weight management based on their superior efficacy.

Clinical trials demonstrate that GLP-1 medications produce weight reductions of 15 to 22 percent of body weight, substantially outperforming topiramate and other older weight loss agents. Tirzepatide, which is a dual GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptor agonist, has shown even greater results in recent research. PlexusDx delivers compounded semaglutide injections starting at $149 per month, with your dose adjusted to your individual response without any price increase.

Why Mechanism of Action Matters for Your Weight Loss Results

The biological pathway a medication targets directly influences how much weight you lose and how well your body tolerates the treatment. Topiramate's effects on general brain calming are indirect and less potent than GLP-1's highly specific appetite and satiety signals. When you choose a medication that matches your body's genetic predispositions and weight loss needs, the results tend to be stronger and side effects more manageable.

PlexusDx offers the Precision Peptide Genetic Test to identify how your body responds to different peptide pathways, including key variants like GLP1R rs6923761 and GIPR rs1800437. This test maps 14 distinct pathways and 49 peptides to reveal which compounds will work best for your unique biology. Understanding your genetic profile helps you avoid trial-and-error approaches and find the most effective therapy from the start.

Choosing Between Topiramate and GLP-1 Medications for Weight Management

If you have a history of seizure disorders or migraines, topiramate may offer dual benefits beyond weight loss, making it worth discussing with your healthcare provider. However, if weight loss is your primary goal and you have no contraindications to GLP-1 therapy, semaglutide or tirzepatide typically deliver more dramatic and sustainable results. The choice depends on your medical history, existing conditions, and how aggressively you want to address excess weight.

PlexusDx serves all 50 states with no insurance required and no membership fees, offering compounded semaglutide injections, oral formulations, tirzepatide options, and combination GLP-Squared protocols. All medications come from licensed 503A compounding pharmacies and are HSA/FSA eligible for added affordability. After your first month on therapy, you can add the Precision Peptide Genetic Test for $99 to optimize your long-term treatment plan based on your genetic profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is topiramate the same as a GLP-1 medication?

No. Topiramate is an anticonvulsant that works by enhancing GABA activity in the brain, while GLP-1 medications like semaglutide directly bind to GLP-1 receptors to control appetite and blood sugar. They operate through completely different biological mechanisms, and GLP-1 drugs typically produce much stronger weight loss results.

How much weight can I expect to lose with topiramate versus semaglutide?

Clinical data shows topiramate produces approximately 5 to 10 percent body weight reduction over several months, while semaglutide achieves 15 to 22 percent reduction in controlled trials. PlexusDx compounded semaglutide injections start at $149 per month and can be titrated to your individual needs without any your dose may need to go up - your price won't increases.

Can I take topiramate and semaglutide together?

Combining medications requires careful medical evaluation by your healthcare provider, as different drug classes may interact. PlexusDx providers work with you to determine the optimal single therapy or, if medically appropriate, personalized combination protocols tailored to your health profile and weight loss goals.

What are the main side effects of topiramate compared to GLP-1 drugs?

Topiramate commonly causes tingling sensations, cognitive dulling, and potential birth defects, limiting its use in women of childbearing age. GLP-1 medications typically cause nausea, which decreases over time as the body adjusts, and they have an established safety profile in both diabetes and weight loss applications across millions of patients.

How does the Precision Peptide Genetic Test help me choose between weight loss medications?

PlexusDx's genetic test examines 14 peptide pathways and 150+ genetic insights, including variants affecting GLP1R and GIPR responsiveness, to predict which compounds will work best for your unique biology. This $99 add-on test after your first month of treatment removes guesswork and helps optimize your long-term results.

Is Topiramate a GLP-1? Understanding the Role of Topiramate in Weight Management